Literature DB >> 12558566

Differential expression of GABA and glutamate-receptor subunits and enzymes involved in GABA metabolism between electrophysiologically identified hippocampal CA1 pyramidal cells and interneurons.

Albert E Telfeian1, Henry C Tseng, Marianna Baybis, Peter B Crino, Marc A Dichter.   

Abstract

PURPOSE: The balance between synaptic excitation and inhibition within the hippocampus is critical for maintaining normal hippocampal function. Even mild reduction in inhibition or enhancement of excitation can produce seizures. Synaptic excitation is produced by pyramidal cells and granule cells, whereas inhibition is produced by a smaller number of interneurons. To understand how two subpopulations of these excitatory and inhibitory neurons are regulated at the molecular level, we analyzed specific mRNA expression profiles for receptors that are significantly involved in synaptic transmission and in the synthesis and storage of the principal inhibitory neurotransmitter, gamma-aminobutyric acid (GABA). Our hypothesis was that differences in gene expression between inhibitory and excitatory neurons in the rat hippocampus might point to specific new targets for seizure pharmacotherapy.
METHODS: We combined the techniques of (a) whole-cell patch clamping in rat hippocampal slices, (b) biocytin staining for cell identification, (c) single-cell mRNA amplification, and (d) small-scale cDNA microarray analysis to allow us to obtain expression profiles for candidate genes from identified CA1 pyramidal neurons and interneurons. Electrophysiologic and morphologic data and expression profiles were obtained from 12 stratum pyramidale and seven stratum radiatum cells.
RESULTS: Presumed inhibitory neurons expressed significantly more GAD65, GAD67, vGAT, GABA(A)-receptor alpha3, and N-methyl-d-aspartate (NMDA)-receptor IIB mRNA, and presumed excitatory neurons expressed more GABA(A)-receptor alpha1, and NMDA-receptor I mRNA.
CONCLUSIONS: Differential expression of candidate neurotransmitter-receptor subunits distinguished CA1 pyramidal neurons from interneurons. These differences may indicate potential new targets for altering the balance of inhibition and excitation in the treatment of epilepsy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12558566     DOI: 10.1046/j.1528-1157.2003.06102.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

Review 1.  Methodological considerations regarding single-cell gene expression profiling for brain injury.

Authors:  Jason E Davis; James H Eberwine; David A Hinkle; Paolo G Marciano; David F Meaney; Tracy K McIntosh
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 2.  What are the mechanisms underlying the involvement of different subtypes of NMDA receptors in inducing long-term potentiation and depression in the hippocampus?

Authors:  I G Sil'kis
Journal:  Neurosci Behav Physiol       Date:  2007-06

3.  Sex and estrogenic effects on coexpression of mRNAs in single ventromedial hypothalamic neurons.

Authors:  N Devidze; J A Mong; A M Jasnow; L-M Kow; D W Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

4.  Increased Kv1 channel expression may contribute to decreased sIPSC frequency following chronic inhibition of NR2B-containing NMDAR.

Authors:  Shuijin He; Li-Rong Shao; W Bradley Rittase; Suzanne B Bausch
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

5.  Role of endoplasmic reticulum stress in the amygdaloid kindling model of rats.

Authors:  Yuri Chihara; Yuto Ueda; Taku Doi; L James Willmore
Journal:  Neurochem Res       Date:  2011-05-22       Impact factor: 3.996

6.  Evidence that injury-induced changes in hippocampal neuronal calcium dynamics during epileptogenesis cause acquired epilepsy.

Authors:  Mohsin Raza; Robert E Blair; Sompong Sombati; Dawn S Carter; Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

7.  Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders.

Authors:  Xiangling Meng; Wei Wang; Hui Lu; Ling-Jie He; Wu Chen; Eugene S Chao; Marta L Fiorotto; Bin Tang; Jose A Herrera; Michelle L Seymour; Jeffrey L Neul; Fred A Pereira; Jianrong Tang; Mingshan Xue; Huda Y Zoghbi
Journal:  Elife       Date:  2016-06-21       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.